These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 19450926

  • 1. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H.
    Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
    [Abstract] [Full Text] [Related]

  • 2. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 4. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L.
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [Abstract] [Full Text] [Related]

  • 5. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ.
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [Abstract] [Full Text] [Related]

  • 6. Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: role of cathepsin G and protease-activated receptor-4.
    Dabek M, Ferrier L, Annahazi A, Bézirard V, Polizzi A, Cartier C, Leveque M, Roka R, Wittmann T, Theodorou V, Bueno L.
    Inflamm Bowel Dis; 2011 Jun; 17(6):1409-14. PubMed ID: 21560201
    [Abstract] [Full Text] [Related]

  • 7. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.
    Dabek M, Ferrier L, Roka R, Gecse K, Annahazi A, Moreau J, Escourrou J, Cartier C, Chaumaz G, Leveque M, Ait-Belgnaoui A, Wittmann T, Theodorou V, Bueno L.
    Am J Pathol; 2009 Jul; 175(1):207-14. PubMed ID: 19528350
    [Abstract] [Full Text] [Related]

  • 8. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.
    Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D, Pierdomenico SD, Cuccurullo F, Neri M.
    Am J Gastroenterol; 2005 Feb; 100(2):383-9. PubMed ID: 15667496
    [Abstract] [Full Text] [Related]

  • 9. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M.
    Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
    [Abstract] [Full Text] [Related]

  • 10. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.
    Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626
    [Abstract] [Full Text] [Related]

  • 11. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR, Jiang K, Zhang QY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):957-60. PubMed ID: 18756966
    [Abstract] [Full Text] [Related]

  • 12. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR, Luo JY, Shang L, Kong WM.
    Chin J Dig Dis; 2006 Apr 08; 7(2):89-96. PubMed ID: 16643336
    [Abstract] [Full Text] [Related]

  • 13. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct 08; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 14. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients.
    Wang P, Chen FX, Du C, Li CQ, Yu YB, Zuo XL, Li YQ.
    Sci Rep; 2015 May 22; 5():10121. PubMed ID: 25998025
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome.
    Ng C, Danta M, Kellow J, Badcock CA, Hansen R, Malcolm A.
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep 22; 289(3):G489-94. PubMed ID: 15905412
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB.
    World J Gastroenterol; 2016 Mar 28; 22(12):3451-9. PubMed ID: 27022227
    [Abstract] [Full Text] [Related]

  • 17. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
    Király A, Csizmadia C, Illés A, Undi S.
    Orv Hetil; 2006 Mar 05; 147(9):421-6. PubMed ID: 16619961
    [Abstract] [Full Text] [Related]

  • 18. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB.
    Am J Gastroenterol; 2003 Jun 05; 98(6):1309-14. PubMed ID: 12818275
    [Abstract] [Full Text] [Related]

  • 19. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia.
    Sipe WE, Brierley SM, Martin CM, Phillis BD, Cruz FB, Grady EF, Liedtke W, Cohen DM, Vanner S, Blackshaw LA, Bunnett NW.
    Am J Physiol Gastrointest Liver Physiol; 2008 May 05; 294(5):G1288-98. PubMed ID: 18325985
    [Abstract] [Full Text] [Related]

  • 20. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L, Bueno L, Wittmann T.
    Digestion; 2012 May 05; 85(1):40-6. PubMed ID: 22179430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.